Abstract
CD44 is a highly glycosylated cell adhesion molecule that is involved in lymphocyte infiltration of inflamed tissues. We have demonstrated previously that sialic acid residues of CD44 negatively regulates its receptor function and CD44 plays an important role in the accumulation of T helper type 2 (Th2) cells in the airway of a murine model of acute asthma. Here we evaluated the role of sialidase in the hyaluronic acid (HA) receptor function of CD44 expressed on CD4+ T cells, as well as in the development of a mite antigen-induced murine model of acute asthma. Splenic CD4+ T cell binding of HA was examined with flow cytometry. Expression of sialidases (Neu1, Neu2, Neu3 and Neu4) in spleen cells was evaluated by quantitative real-time reverse transcription-polymerase chain reaction. Airway inflammation and airway hyperresponsiveness (AHR) were evaluated in the asthmatic Neu1-deficient mouse strain SM/J model. Splenic CD4+ T cells from asthmatic model mice displayed increased HA receptor activity of CD44 after culture with the antigen, along with characteristic parallel induction of sialidase (Neu1) expression. This induction of HA binding was suppressed significantly by a sialidase inhibitor and was not observed in SM/J mice. Th2 cytokine concentration and absolute number of Th2 cells in the bronchoalveolar lavage fluid, and AHR were decreased in SM/J mice. In conclusion, HA receptor activity of CD44 and acute asthmatic reactions, including Th2-mediated airway inflammation and AHR, are dependent upon Neu1 enzymatic activity. Our observation suggests that Neu1 may be a target molecule for the treatment of asthma.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antigens, Dermatophagoides / immunology
-
Asthma / genetics
-
Asthma / immunology*
-
Asthma / physiopathology*
-
Azides / pharmacology
-
Bronchial Hyperreactivity / immunology
-
Bronchial Hyperreactivity / physiopathology
-
Bronchoalveolar Lavage Fluid / cytology
-
Bronchoalveolar Lavage Fluid / immunology
-
CD4-Positive T-Lymphocytes / drug effects
-
CD4-Positive T-Lymphocytes / immunology
-
CD4-Positive T-Lymphocytes / metabolism
-
Cell Count
-
Chemokine CCL11 / metabolism
-
Enzyme Inhibitors / pharmacology
-
Eosinophils / cytology
-
Eosinophils / immunology
-
Female
-
Gene Expression / drug effects
-
Gene Expression / genetics
-
Gene Expression / immunology
-
Hyaluronan Receptors / metabolism*
-
Hyaluronic Acid / metabolism
-
Inflammation / immunology
-
Inflammation / pathology
-
Interferon-gamma / metabolism
-
Interleukins / metabolism
-
Lymph Nodes / cytology
-
Lymph Nodes / immunology
-
Lymphocyte Activation / immunology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred DBA
-
Mice, Mutant Strains
-
Neuraminidase / antagonists & inhibitors
-
Neuraminidase / genetics
-
Neuraminidase / metabolism*
-
Neuraminidase / pharmacology
-
Peanut Agglutinin / metabolism
-
Sialic Acids / pharmacology
-
Spleen / cytology
-
Spleen / enzymology
-
Spleen / immunology
-
Th1 Cells / cytology
-
Th1 Cells / immunology
-
Th1 Cells / metabolism
-
Th2 Cells / cytology
-
Th2 Cells / immunology*
-
Th2 Cells / metabolism*
-
Vaccination
Substances
-
Antigens, Dermatophagoides
-
Azides
-
Ccl11 protein, mouse
-
Cd44 protein, mouse
-
Chemokine CCL11
-
Enzyme Inhibitors
-
Hyaluronan Receptors
-
Interleukins
-
Peanut Agglutinin
-
Sialic Acids
-
5-N-acetyl-9-(4-azidosalicoylamido)-2-deoxy-2,3-didehydroneuraminic acid
-
Interferon-gamma
-
Hyaluronic Acid
-
Neu1 protein, mouse
-
Neuraminidase